Home›Health›No Hydroxychloroquine Benefit in Randomized COVID-19 Trial

No Hydroxychloroquine Benefit in Randomized COVID-19 Trial

March 2, 2024

568

[ad_1]

The 150-patient trial has problems of confounding, according to two experts, and is unable to answer definitively whether hydroxychloroquine can benefit COVID-19 patients or harm them.

[ad_2]

Fitcoachion

At this moment, I am a doctor and a health blogger. I wrote my first blog post in 2008 about a new symptom I had experienced with my skin. By 2011, I was writing almost weekly about medical topics and had become a contributing writer at fitcoachion.com. It didn't take me long to realize that this was what I wanted to do for the rest of my life. In 2014, I started working as a doctor and have written more than 25,000 words in that capacity. In addition to working as a doctor, I have also worked as a public relations specialist and as an English tutor.